We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Stockal+Disclaimer.pdf
11 own
13 watching
Current Price
$89.25
$0.37
(0.42%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
2,603.05M
52-Week High
99.63000
52-Week Low
36.42000
Average Volume
0.44M
Dividend Yield
--
P/E Ratio
--
Market Capitalization2,603.05M52-Week High99.6300052-Week Low36.42000Average Volume0.44MDividend Yield--P/E Ratio--What does the Stockal+Disclaimer.pdf do?
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
Read More
How much money does Stockal+Disclaimer.pdf make?
News & Events about Stockal+Disclaimer.pdf.
Fool.com Headlines
11 months ago
Shares of this high-flying healthcare stock stumbled recently despite an outstanding performance in the first few months of 2023.If you've been looking for growth stocks with explosive potential, you've probably noticed that a company called TransMedics Group (NASDAQ: TMDX) has practically tripled ...
Zolmax
11 months ago
TransMedics Group, Inc. (NASDAQ:TMDX Get Rating) CEO Waleed H. Hassanein sold 7,500 shares of the businesss stock in a transaction that occurred on Monday, May 1st. The shares were sold at an average price of $78.13, for a total value of $585,975.00. Following the completion of the transaction, the ...
Ticker Report
11 months ago
TransMedics Group, Inc. (NASDAQ:TMDX Get Rating) CEO Waleed H. Hassanein sold 7,500 shares of the stock in a transaction dated Monday, May 1st. The shares were sold at an average price of $78.13, for a total transaction of $585,975.00. Following the completion of the sale, the chief ...
PR Newswire
12 months ago
TransMedics Releases Inaugural Environmental, Social & Governance (ESG) Report TransMedics Releases Inaugural Environmental, Social & Governance (ESG) Report PR Newswire ANDOVER, Mass., May 1, 2023 ANDOVER, Mass., May 1, 2023 /PRNewswire/ -- TransMedics Group, Inc...
Ticker Report
1 year ago
TransMedics Group, Inc. (NASDAQ:TMDX Get Rating) insider Tamer I. Khayal sold 35,930 shares of the stock in a transaction dated Thursday, February 23rd. The shares were sold at an average price of $73.51, for a total value of $2,641,214.30. Following the completion of the sale, the insider ...
Frequently Asked Questions
Frequently Asked Questions
What is Stockal+Disclaimer.pdf share price today?
Can Indians buy Stockal+Disclaimer.pdf shares?
How can I buy Stockal+Disclaimer.pdf shares from India?
Can Fractional shares of Stockal+Disclaimer.pdf be purchased?
What are the documents required to start investing in Stockal+Disclaimer.pdf stocks?
What is today’s traded volume of Stockal+Disclaimer.pdf?
What is today’s market capitalisation of Stockal+Disclaimer.pdf?
What is the 52-Week High and Low Range of Stockal+Disclaimer.pdf?
What percentage is Stockal+Disclaimer.pdf down from its 52-Week High?
What percentage is Stockal+Disclaimer.pdf up from its 52-Week Low?
Current Price
$89.25
$0.37
(0.42%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.